|

Doxorubicin Hydrochloride Liposome Injection Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 2Phase 1/2: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
  • Jiangsu HengRui Medicine Co., Ltd.1
  • Fudan University1

Indications

  • Cancer3
  • Ovarian Cancer2
  • Breast Cancer1

Other3 trials

A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
Phase 1/2
A Study of SHR-A1811 in Subjects With Ovarian Cancer
Phase 3
Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.